When did Claritas Pharmaceuticals stock split?

Claritas Pharmaceuticals, Inc. (OTCMKTS:KALTF) posted its quarterly earnings data on Friday, November, 29th. The company reported ($0.40) earnings per share (EPS) for the quarter. When did Claritas Pharmaceuticals' stock split? Claritas Pharmaceuticals's stock reverse split on Friday, July 23rd 2021.

What does Claritas pharmaceuticals do?

Claritas Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The Company focuses on developing and commercializing therapies for patients with significant unmet medical needs. Claritas Pharmaceuticals serves customers worldwide.

Does Claritas pharmaceuticals (clazf) have a liquid biopsy test?

It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too. Find the latest Claritas Pharmaceuticals, Inc. (CLAZF) stock quote, history, news and other vital information to help you with your stock trading and investing.

What is the Claritas Investment Certificate?

The Claritas Investment Certificate is a program that focuses on investment industry basics and the roles and responsibilities of financial services professionals. The program is an online, self-study course, with seven course modules covering various topics, such as industry controls and ethics and regulations.